Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Anti-CD19/CD20/CD22 CAR-T Cells |
Trade Name | |
Synonyms | |
Drug Descriptions |
Anti-CD19/CD20/CD22 CAR-T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19, CD20, and CD22, which may induce antitumor activity (Blood (2022) 140 (Supplement 1): 7474–7475). |
DrugClasses | CD19 Immune Cell Therapy 62 CD20 Immune Cell Therapy 11 CD22 Immune Cell Therapy 15 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Anti-CD19/CD20/CD22 CAR-T Cells | Anti-CD19/CD20/CD22 CAR-T Cells | 0 | 1 |